Cargando…
Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743355/ http://dx.doi.org/10.1038/sj.bjc.6605295 |
| _version_ | 1782171858156650496 |
|---|---|
| author | Park, Y Okamura, K Mitsuyama, S Saito, T Koh, J Kyono, S Higaki, K Ogita, M Asaga, T Inaji, H Komichi, H Kohno, N Yamazaki, K Tanaka, F Ito, T Nishikawa, H Osaki, A Koyama, H Suzuki, T |
| author_facet | Park, Y Okamura, K Mitsuyama, S Saito, T Koh, J Kyono, S Higaki, K Ogita, M Asaga, T Inaji, H Komichi, H Kohno, N Yamazaki, K Tanaka, F Ito, T Nishikawa, H Osaki, A Koyama, H Suzuki, T |
| author_sort | Park, Y |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2743355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27433552010-09-15 Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study Park, Y Okamura, K Mitsuyama, S Saito, T Koh, J Kyono, S Higaki, K Ogita, M Asaga, T Inaji, H Komichi, H Kohno, N Yamazaki, K Tanaka, F Ito, T Nishikawa, H Osaki, A Koyama, H Suzuki, T Br J Cancer Corrigendum Nature Publishing Group 2009-09-15 2009-09-08 /pmc/articles/PMC2743355/ http://dx.doi.org/10.1038/sj.bjc.6605295 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum Park, Y Okamura, K Mitsuyama, S Saito, T Koh, J Kyono, S Higaki, K Ogita, M Asaga, T Inaji, H Komichi, H Kohno, N Yamazaki, K Tanaka, F Ito, T Nishikawa, H Osaki, A Koyama, H Suzuki, T Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title | Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title_full | Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title_fullStr | Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title_full_unstemmed | Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title_short | Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study |
| title_sort | uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage i, ii, or iiia lymph node-positive breast cancer: a comparative study |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743355/ http://dx.doi.org/10.1038/sj.bjc.6605295 |
| work_keys_str_mv | AT parky uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT okamurak uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT mitsuyamas uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT saitot uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT kohj uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT kyonos uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT higakik uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT ogitam uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT asagat uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT inajih uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT komichih uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT kohnon uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT yamazakik uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT tanakaf uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT itot uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT nishikawah uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT osakia uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT koyamah uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy AT suzukit uraciltegafurandtamoxifenversuscyclophosphamidemethotrexatefluorouracilandtamoxifeninpostoperativeadjuvanttherapyforstageiiioriiialymphnodepositivebreastcanceracomparativestudy |